Key result
Antihypertensive therapies in pediatric patients require careful selection based on the underlying cause and severity of hypertension, with limited data available on long-term cardiovascular outcomes.
Why the study?
Pediatric hypertension is rising alongside obesity and often persists into adulthood, increasing the risk of cardiovascular and renal disease, making a review of its management necessary.
What is the safety and efficacy of antihypertensive drugs used in pediatric patients?
What is the safety and efficacy of antihypertensive drugs used in pediatric patients?
This review emphasizes the growing burden of pediatric hypertension globally and the importance of early pharmacological management to prevent adult cardiovascular and renal disease.
An established graded connection between childhood hypertension and adult hypertension places adult hypertension among the main preventable causes of premature death.A parallel trend that could lead to an exponential rise in cardiovascular, cerebrovascular, and renal disasters is unfolding in developing nations, with the concurrent growth in obesity and pediatric hypertension (HTN) over the previous 10 years in wealthy nations.It is rather alarming that China and India have cumulative pediatric HTN incidence rates of 50-70% and 23%, respectively.A review of pediatric hypertension and its management is necessary to address this under-attended burning issue, which is reflected in new guidelines for detecting, evaluating, and managing hypertension in children and adolescents published in 2017.These guidelines noted a rise in pediatric HTN prevalence.Early diagnosis and treatment of HTN are crucial since it typically persists into adulthood and is a risk factor for both renal and cardiovascular disease progression.We will learn about treating pediatric HTN in this review.
No takes yet. Share an insight, caveat, or question.
Patil et al. (2023) conducted a review in Pediatric hypertension. Antihypertensive drugs was evaluated. Antihypertensive therapies in pediatric patients require careful selection based on the underlying cause and severity of hypertension, with limited data available on long-term cardiovascular outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: